NewSpring HealthCare is a private equity general partner firm.
Paragon Bioservices, a contract research and manufacturer focused on biopharmaceuticals and vaccines, has named John Conner as senior VP.
NewSpring Capital has sold its stake in RedPath, a molecular diagnostics lab, to PDI.
Paragon Bioservices, a Baltimore-based contract research and manufacturing organization, has raised $13m from Camden Partners and others.
Read more news concerning NewSpring HealthCare
A sampling of NewSpring HealthCare portfolio companies:
View all of the investments in their portfolio
This firm also pursues other investment strategies:
Registration is fast, free and easy
Already a member?